Management

Jon Askaa
CEO. Dr. Askaa comes from a position as Director of Companion Diagnostics at Genentech Inc and has been responsible for development and implementation of Companion Diagnostic assays for Genentech's targeted therapy programs. Before that he worked at Dako in Denmark and in California and was responsible for the development and launch of the HercepTest companion diagnostic and several other Companion Diagnostic assays.
Phone: +45 26 20 64 45
E-mail: jon.askaa@medical-prognosis.com

Steen Knudsen
Founder and CSO. Dr. Knudsen was previously a Professor at the Technical University of Denmark and has authored several books on DNA microarrays.
Phone: +45 20 86 52 06
E-mail: steen@medical-prognosis.com

 

 

Announcements

MPI publishes Exercise Response Predictor

MPI, together with...
Read more

New CEO as of January 1, 2010.
MPI is proud to announce...
Read more

Blind clinical validation of drug response predictor

...
Read more

Medical Prognosis Institute A/S, Venlighedsvej 1, 2970 Hørsholm, Denmark
© Copyright 2009 MPI A/S